JONES ERIN (See Remarks) sold 3.7% of their position (13.75K shares) of GRITSTONE BIO, INC. on the open market
Open‑market sale worth $10.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/17/2024ACC: 0001415889-24-013656
Officer· See Remarks
Since Sep 2018
+248.38K
Net shares
Net buyer
$10.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
262.13K acquired · 13.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.13K
Price / share
—
Trade value
—
% of position
7.8%
5/15/2024
345.91K→373.04K
Common Stock
Direct
Shares
−13.75K
Price / share
$0.75
Trade value
$10.29K
% of position
3.7%
5/16/2024
373.04K→359.29K
Total
Net shares
+13.38K
Net value
-$10.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2024 | A · Award | +27.13K | — | — | 7.8% | 345.91K | 373.04K |
| Common Stock Direct | 5/16/2024 | S · Sale | −13.75K | $0.75 | $10.29K | 3.7% | 373.04K | 359.29K |
| Total | +13.38K | -$10.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
235K shares
Shares
+235K
Strike price
0.75
Held after
235K
Exercisable
—
5/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock235K shares | 5/15/2024 | A · Award | +235K | 0.75 | — | 235K |